ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Sees Significant Growth in Short Interest
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Sees Significant Growth in Short Interest
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Rating) was the recipient of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 16,700 shares, a growth of 12.1% from the January 15th total of 14,900 shares. Based on an average daily trading volume, of 18,300 shares, the days-to-cover ratio is currently 0.9 days.
ProShares UltraShort 纳斯达克生物技术公司(纳斯达克股票代码:BIS — 获取评级)是1月份空头利率大幅增长的受益者。截至1月31日,空头利息总额为16,700股,较1月15日的14,900股增长了12.1%。根据18,300股的平均每日交易量,目前的天数回报率为0.9天。
Institutional Investors Weigh In On ProShares UltraShort Nasdaq Biotechnology
机构投资者关注ProShares UltraShort 纳斯达克生物技术公司
A number of institutional investors have recently added to or reduced their stakes in the company. IMC Chicago LLC lifted its stake in ProShares UltraShort Nasdaq Biotechnology by 11.1% during the third quarter. IMC Chicago LLC now owns 23,335 shares of the company's stock worth $590,000 after purchasing an additional 2,332 shares during the period. Citadel Advisors LLC lifted its stake in ProShares UltraShort Nasdaq Biotechnology by 234.0% during the second quarter. Citadel Advisors LLC now owns 34,972 shares of the company's stock worth $943,000 after purchasing an additional 24,501 shares during the period. Finally, UBS Group AG lifted its stake in ProShares UltraShort Nasdaq Biotechnology by 236,300.0% during the fourth quarter. UBS Group AG now owns 2,364 shares of the company's stock worth $46,000 after purchasing an additional 2,363 shares during the period.
许多机构投资者最近增加了或减少了在该公司的股份。IMC Chicago LLC在第三季度将其在ProShares UltraShort Nasdaq Biotechology的股份提高了11.1%。IMC Chicago LLC在此期间又购买了2,332股股票后,现在拥有该公司23,335股股票,价值59万美元。Citadel Advisors LLC在第二季度将其在ProShares UltraShort Nasdaq Biotechology的股份提高了234.0%。Citadel Advisors LLC在此期间又购买了24,501股股票后,现在拥有该公司34,972股股票,价值94.3万美元。最后,瑞银集团股份公司在第四季度将其在ProShares UltraShort Nasdaq Biotechology的股份提高了236,300.0%。瑞银集团股份公司在此期间又购买了2,363股股票后,现在拥有该公司2364股股票,价值46,000美元。
ProShares UltraShort Nasdaq Biotechnology Stock Up 2.8 %
ProShares UltraShort 纳斯达克生物技术股票上涨2.8%
Shares of NASDAQ:BIS opened at $19.71 on Friday. The stock's 50-day moving average is $19.01 and its 200-day moving average is $21.16. ProShares UltraShort Nasdaq Biotechnology has a 52-week low of $17.88 and a 52-week high of $35.64.
纳斯达克:国际清算银行股票周五开盘价为19.71美元。该股的50天移动平均线为19.01美元,其200天移动平均线为21.16美元。ProShares UltraShort 纳斯达克生物技术公司的52周低点为17.88美元,52周高点为35.64美元。
ProShares UltraShort Nasdaq Biotechnology Company Profile
ProShares UltraShort 纳斯达克生物技术公司简介
(Get Rating)
(获取评分)
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.
ProShares Ultra Nasdaq 生物技术公司(以下简称 “基金”)仅寻求单日的投资业绩,而不是长期的投资业绩。该基金寻求扣除费用和支出前的每日投资业绩,这些业绩相当于该指数每日表现的两倍(200%)。基金在超过一个交易日的时间内的回报将是该期间每天的复合回报的结果,这很可能与该时期纳斯达克生物技术指数(“指数”)回报率的两倍(200%)有所不同。
Featured Stories
精选故事
- Get a free copy of the StockNews.com research report on ProShares UltraShort Nasdaq Biotechnology (BIS)
- Bloomin' Brands Blossoms After Raising The Dividend
- Zebra Technologies: A Reversal Is In Play
- Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead
- The S&P 500: Don't Trust The Wave Of Bullish Sentiment
- Cisco Systems Is Ready To Run Higher
- 免费获取 StockNews.com 关于 ProShares UltraShort 纳斯达克生物技术(BIS)的研究报告
- Bloomin'Brands 在提高股息后蓬勃发展
- 斑马科技:逆转正在发生
- Pet-Med 专家 Zoetis 未来将实现两位数的收益增长
- 标普500指数:不要相信看涨情绪的浪潮
- 思科系统已准备好运行得更高
Receive News & Ratings for ProShares UltraShort Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
接收ProShares UltraShort《纳斯达克生物技术日报》的新闻和评级——在下方输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收ProShares UltraShort Nasdaq Biotechorty及相关公司的最新新闻和分析师评级的简明每日摘要。